Lim Soon Thye MBBS, MRCP

Dr. Lim Soon Thye graduated from the National University of Singapore and subsequently obtained his membership with the Royal College of Physician (UK). He received specialist training in medical oncology at the National Cancer Centre Singapore and further training in lymphoid malignancies at the University of Southern California.

Currently, he is a senior consultant and head of medical oncology at NCCS. He is also the director of SingHealth-Duke NUS Blood Cancer Centre and a professor at Duke-NUS medical school. His other administrative duties include being the chairman of the SingHealth central institutional review board-B, director of ACP oncology clinical service and chairman of the national medical oncology residency advisory committee. Dr. Lim previously served as the president of the Singapore Society of Oncology from 2006 to 2010 and chairman of the chapter of Medical Oncologist, Academy of Medicine Singapore from 2010 to 2014. He is an active council member at the Singapore Cancer Society.

Dr Lim’s research focus is on lymphoid malignancies; in particular T and NK/T cell lymphomas, that occur more frequently in Asia. He is the co-founder of the Asian Lymphoma Study Group, which includes academic medical centres across Asia. Currently, Dr Lim is also the lead investigator of a translational and clinical Research (TCR) flagship programme funded by NMRC (National Lymphoma Translational Research Program: From Genomics to Therapeutics). His team now leads the blood cancer (T cell lymphoma) genomics project at the International Cancer Genomics Consortium.